TickerFacts.

Roivant Sciences Ltd. (ROIV): Share Repurchases

Annual figures by period end, from SEC filings.

$1.29B
Year ended 2025-03-31
2023-03-31: $02024-03-31: $02025-03-31: $1.29B$1.29B
2023-03-31 Share Repurchases (USD) 2025-03-31
Period endedShare RepurchasesChange YoYSource filing
2025-03-31$1.29Bn/a2025-05-29, From 2024-04-01
2024-03-31$0n/a2025-05-29, From 2023-04-01
2023-03-31$0n/a2025-05-29, From 2022-04-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Roivant Sciences Ltd. (ROIV)2025-03-31$1.29Bn/a
Tonix Pharmaceuticals Holding Corp. (TNXP)2025-12-31$13.76Mn/a
ProPhase Labs, Inc. (PRPH)2024-12-31$0-100.0%
CASI Pharmaceuticals, Inc. (CASIF)2023-12-31$278.0K-91.5%
Alumis Inc. (ALMS)2025-12-31$17.0K+183.3%
Cue Biopharma, Inc. (CUE)2023-12-31$0-100.0%
Earth Science Tech, Inc. (ETST)2026-03-31$471.4K-67.8%
Sunshine Biopharma Inc. (SBFM)2025-12-31$0-100.0%
Lftd Partners Inc. (LIFD)2025-12-31$0-100.0%

Compare ROIV, TNXP, PRPH, CASIF side by side · Screen every company in Pharmaceutical Preparations ↗